(ÁÖ)Çѵ¶ ½ÅÀÔ ¹× °æ·Â ¼ö½Ãä¿ë

¸ðÁýºÎ¹®

[½ÅÀÔ/°æ·Â] RA (Regulatory Affairs) ¸ðÁý
°ø°í¸¶°¨ÀÏ
  • 2024/10/13
±Ù¹«Áö
  • Çѵ¶ º»»ç (¼­¿ï½Ã °­³²±¸ Å×Çì¶õ·Î 132)
°æ·Â±¸ºÐ
  • ½ÅÀÔ/°æ·Â
Á÷¹«»ó¼¼
  • ÁÖ¿ä ÀǾàÇ° Ç°¸ñ¿¡ ´ëÇØ Àü·«ÀûÀ¸·Î µî·Ï °èȹÀ» ¼ö¸³ÇÏ°í À̸¦ ½ÇÇàÇÏ¿© ¸ñÇ¥ÇÑ ½Ã°£ ³»¿¡ ÃÖ¼±ÀÇ »çÇ×À¸·Î Ç°¸ñ Çã°¡(¶Ç´Â Çã°¡ º¯°æ), ÀÓ»ó½ÃÇè°èȹ½ÂÀÎÀ» µæÇÔ
    • ÀǾàÇ°ÀÇ ½Å±Ô Çã°¡, Çã°¡ º¯°æ ¶Ç´Â ±¹³» ÀÓ»ó ½ÃÇè ½ÂÀÎÀ» ¹Þ±â À§ÇÑ ÀÏÁ¤À» ¼¼¿ì°í, ¿ä±¸µÇ´Â ÀڷḦ ÀÛ¼ºÇÏ¿© ½ÅûÇÏ°í, ÃÖ¼±ÀÇ Çã°¡»çÇ× µîÀ» ȹµæÇϵµ·Ï ½Ä¾àó µî °ü·Ã±â°ü°ú »óÈ£ÀÛ¿ëÇϸç, ÀÏÁ¤ ¹× ÁøÇà»óȲ µî¿¡ ´ëÇÑ Á¤º¸¸¦ °ü·Ã ºÎ¼­ µî¿¡ °øÀ¯µÇµµ·Ï Å뺸Çϸç, °ü·ÃÀڷḦ ±â·ÏÇÏ°í º¸°üÇÔ..
    • ÀáÀçÀû ¹®Á¦Á¡¿¡ ´ëÇØ ¹Ì¸® ÆľÇÇÏ°í ¸Å´ÏÀú¿Í »óÀÇÇÏ¿© ¹æ¾ÈÀ» ¸ð»öÇÏ°í ´ëóÇÔ.
  • µµÀÔ ¶Ç´Â °³¹ß °ËÅäÁßÀÎ Á¦Ç°/ÇÁ·ÎÁ§Æ®¿¡ ´ëÇØ ÇâÈÄ ¹ý±Ô °³Á¤ µîÀ» °í·ÁÇÏ¿© µî·Ï°¡´É¼ºÀ» °ËÅäÇÏ°í ÀûÀýÇÑ µî·ÏÀÏÁ¤À» ¼ö¸³ÇÔ
    • ±¹³»¿¡¼­ ÀǾàÇ°ÀÇ µî·Ï °¡´É¼º ¹× ¿ä°ÇÀ» °ËÅäÇÏ°í °ü·ÃºÎ¼­¿¡ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÔ.
  • ¾à»ç¹ý¿¡¼­ ¿ä±¸µÇ´Â »çÇ׵鿡 ÀûÀýÈ÷ ´ëóÇÏ¿© regulatory compliance¸¦ À¯ÁöÇÏ°í business¿¡ ¹ÌÄ¡´Â ¿µÇâÀÌ ÃÖ¼ÒÈ­ µÇµµ·Ï °ü¸®ÇÔ.
    • ¾à»ç °ü·Ã¹ý±Ô¿Í °ü·ÃÇÑ Çؼ® ¹× ÀÚ¹®À» Á¦°ø
    • ¾à»ç°ü·Ã¹ý±ÔÀÇ Á¦°³Á¤ ³»¿ëÀ» ¼öÁýÇÏ°í À̵éÀÌ È¸»ç¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æò°¡ÇÏ¿© °ü·Ã ºÎ¼­¿Í °øÀ¯ÇÏ°í ´ëÀÀÃ¥À» ¸¶·ÃÇϰųª ȸ»ç Â÷¿øÀÇ ÀÇ°ßÀ» ¼ö·ÅÇÏ¿© Á¦Ãâ
    • Business¿¡ ¹®Á¦°¡ »ý±âÁö ¾Êµµ·Ï ÇÊ¿äÇÑ º¯°æÇã°¡ µîÀ» °èȹÇÏ°í ÁøÇà
    • Ç°¸ñÇã°¡ °»½Å/¿¬Â÷º¸°í µî °ü¸®
Áö¿øÀÚ°Ý
  • ±³À°¼öÁØ Education: ¾àÇÐ ¶Ç´Â È­ÇÐ, »ý¹° °ü·Ã Çлç ÇÐÀ§ º¸À¯ÀÚ (¾à»ç ¸éÇã ¼ÒÀ¯ÀÚ ¿ì´ë)
  • °æÇè & Áö½Ä Experience & knowledge:
    • ÀǾàÇ°(¹ÙÀÌ¿À ÀǾàÇ° Æ÷ÇÔ)ÀÇ ÀÛ¿ë ±âÀü ¹× Á¦Ç° °ü·Ã Áö½ÄÀÇ ÀÌÇØ
    • CTD µî Çã°¡ÀÚ·á¿¡ ´ëÇÑ ÀÌÇØ
    • ¾à»ç ¹ý±Ô ¹× ÀǾàÇ° °ü·Ã ±ÔÁ¤, °¡À̵å¶óÀο¡ ´ëÇÑ ÀÌÇØ
    • ÀÓ»ó/¾à°¡/QC.QA/MKTG/SCM °ü·Ã ¾÷¹« ÀÌÇØ
    • ÄÄÇ»ÅÍ È°¿ë ´É·Â(ÇѱÛ, MS Office, ÀÎÅÍ³Ý °Ë»ö µî)
    • ¿µ¾î Àбâ/¾²±â/¸»ÇÏ±â µî ¿øÈ°ÇÑ ¿µ¾î communication
  • Çٽɿª·® / ½ºÅ³ Core competencies /skills:
    • ¾à»ç¹ý±Ô ¹× ÀǾàÇ° °ü·Ã ±ÔÁ¤/°¡À̵å¶óÀÎ ¿¡ ´ëÇÑ ÀÌÇØ ¹× ÀÀ¿ë
    • Á¦Ç° ¹× Áúº´°ü·Ã Áö½Ä
    • °èȹ¼ö¸³°ú ÇÁ·ÎÁ§Æ® °ü¸®
    • Çã°¡ ¼­·ùÀÇ ÀÛ¼º
    • ¹®Á¦ ÇØ°á
    • È¿°úÀû ´ëÀΰü°è ¹× Ä¿¹Â´ÏÄÉÀ̼Ç
[°æ·Â] ºñ´¢±â Àü¹®ÀǾàÇ° Marketing
°ø°í¸¶°¨ÀÏ
  • 2024/10/20
±Ù¹«Áö
  • Çѵ¶ º»»ç (¼­¿ï½Ã °­³²±¸ Å×Çì¶õ·Î 132)
°æ·Â±¸ºÐ
  • °æ·Â
Á÷¹«»ó¼¼ Àü¹®ÀǾàÇ° ºñ´¢±â Áúȯ Á¦Ç°_Åäºñ¾ÖÁî, ½Ã¾Ë¸®½º À» ´ã´çÇÏ´Â PCQE (Primary Care Quality of life Enhancement) Marketing

[Àü¹®ÀǾàÇ°] Á¦Ç° - Àü¹®ÀǾàÇ° | Çѵ¶ (handok.co.kr)
  1. Marketing planning£¦implementation
    • Resource allocation: Products mix against targets, A£¦P allocation efficiency
    • Long-term franchise strategy and planning: portfolio growth, alliance/business partnership
    • Timely report the supervisor according to objectives mutually agreed upon from year-to-year.
    • Take a ownership of specific brand performance measures
    • Perform developmental project base such as secondary market research, data analysis and etc.
    • Conduct a variety of administrative functions such as medical legal mark-ups, material development, clinical study utilization£¦field force communication, all essential to the day to day operation of the brand
  2. Key customer management :
    • Regular visit to target physicians
    • Provide physicians with updated highly scientific information on product£¦disease
    • Shape physicians¡¯ view on the disease and establish need for product
  3. Scientific program support
    • Develop key speakers to become strong advocates for the product£¦therapeutic class
    • Lead scientific initiatives to build clinical evident and implement medical programs
    • Search£¦provide updated articles on the product and develop key message
    • Deliver MR product training
  4. People, Capabilities, and Management:
    • Talent acquisition
    • Responsible for compliance with all legal requirements of company policies and ensure strict compliance
Áö¿øÀÚ°Ý
  • Àü¹®ÀǾàÇ° ¸¶ÄÉÆà °æ·Â 3³â ÀÌ»ó (Urology Á¦Ç° °æÇè ¿ì´ë)
  • MR ¿µ¾÷ °æÇè º¸À¯ÀÚ ¿ì´ë
  • ÇØ¿Ü ÆÄÆ®³Ê»ç¿Í ¿øÈ°ÇÑ ¼ÒÅëÀÌ °¡´ÉÇÑ ¿µ¾î ¼öÁØ
  • Multi-National Company °æÇè º¸À¯ÀÚ ¿ì´ë
[°æ·Â] ¸¸¼ºÁúȯ MSL(Medical Science Liaison) Manager
°ø°í¸¶°¨ÀÏ
  • 2024/10/27
±Ù¹«Áö
  • Çѵ¶Ä·ÆÛ½º (ÃæºÏ À½¼º)
°æ·Â±¸ºÐ
  • °æ·Â
Á÷¹«»ó¼¼ Çѵ¶ MSL manager´Â ÀÇÇкÎÀÇ ÀÏ¿øÀ¸·Î¼­, °úÇÐÀû ±Ù°Å¸¦ ±â¹ÝÀ¸·Î Á¦Ç°ÀÇ ¿Ã¹Ù¸¥ °¡Ä¡(value) ¸¦ ã¾Æ³»°í, À̸¦ °´°üÀûÀÌ°í ±ÕÇüÀâÈù ¹æ½ÄÀ¸·Î °í°´¿¡°Ô Àü´Þ,¼ÒÅë,±³·ùÇÔÀ¸·Î½á ÁøÁ¤ÇÑ È¯ÀÚ Á߽ɼº (Patient centricity)À» ±¸ÇöÇÔÀ» ¸ñÀûÀ¸·Î ÇÑ´Ù.

MSL Manager´Â ´ÙÀ½°ú °°Àº ¿ªÇÒ°ú Ã¥ÀÓÀÌ ÀÖ´Ù.
  1. MSL ¾÷¹« ÄÚĪ ¹× ¼ºÀå ¹ßÀüÀ» Áö¿øÇÔ
  2. ÀÇÇкÎÀÇ Medical Strategy & Plan ¼ö¸³ ¹× ¹æÇ⼺ Á¦½Ã
  3. È¿°úÀûÀÎ MTL (Medical Thought Leader) Engagement
  4. ÀÓ»ó ¿¬±¸ÀÇ È¿À²Àû °ü¸® ¹× Áö¿ø
  5. °ü·Ã Á¦Ç° ¹× Áúȯ¿¡ ´ëÇÑ ÀÇÇÐ ±³À° Áö¿ø
Áö¿øÀÚ°Ý Çѵ¶ MSL Manager´Â Àü¹®¼ºÀ» ¹ÙÅÁÀ¸·Î ÆÀ¿øÀÎ MSLÀÇ ¸ð¹üÀÌ µÇ¾î¾ß ÇÏ°í ³»ºÎ ¹× ¿ÜºÎ °í°´À¸·ÎºÎÅÍ ½Å·Ú¹Þ´Â ÆÄÆ®³Ê°¡ µÇ¾î¾ß ÇÑ´Ù. .

MSL ManagerÀÇ ÀÚ°Ý ¿ä°Ç
  1. MSL °æ·Â 5³â ÀÌ»ó
  2. people management °æ·Â ¿ì´ë
  3. ¾à»ç ȤÀº À¯°üÇаú (»ý¹°ÇÐ, »ý¸í°úÇÐ µî) Á¹¾÷ÀÚ ¼±È£
MSL Manager ÀÇ Çʼö Á¶°Ç/¿ª·®
  1. ÀÇÇкÎÀÇ ºñÀü ¹× Àü·« ¼ö¸³, ¹æÇ⼺ Á¦½Ã
  2. È¿°úÀûÀÎ ÆÀ¿ø ÄÚĪ ¹× Çǵå¹é ½ºÅ³,
  3. °í°´°úÀÇ È¿°úÀûÀÎ ÀÇ»ç¼ÒÅë ´É·Â ¹× °í°´ÁöÇâ ¸¶Àεå
  4. Research; ÀÓ»ó ¿¬±¸ µðÀÚÀÎ ¹× °á°ú Çؼ® ´É·Â
  5. ´Ù¾ç¼º¿¡ ´ëÇÑ Æ÷¿ë·Â ¹× °ø°¨´É·Â
[°æ·Â] ±³Á¤/SCADA ´ã´çÀÚ
°ø°í¸¶°¨ÀÏ
  • 2024/10/27
±Ù¹«Áö
  • Çѵ¶À½¼º°øÀå (ÃæºÏ À½¼º)
°æ·Â±¸ºÐ
  • °æ·Â
Á÷¹«»ó¼¼
  1. »ý»êÀåºñ ¸ð´ÏÅ͸µ/Á¦¾î ½Ã½ºÅÛ(SCADA) ÇÁ·Î±×·¥ À¯Áö°ü¸®
  2. Global GMP ±ÔÁ¤¿¡ µû¸¥ ±³Á¤ °ü¸®
    • »ý»ê ¹× QC ¼³ºñ °èÃø±â ±³Á¤ ¹× ¿Âµµ¸ÊÇÎ
  3. SOP ¹× GMP ¹®¼­ÀÇ ÀÛ¼º ¹× °ü¸®
Áö¿øÀÚ°Ý
  1. Àü±â °ü·Ã Àü°ø 2³âÁ¦ ÃÊ´ëÁ¹ ÀÌ»ó Á¹¾÷ÀÚ
  2. PLC ¹× SCADA ÇÁ·Î±×·¥ È°¿ë °¡´ÉÀÚ
  3. MS Office »ç¿ë °¡´ÉÀÚ(¿¢¼¿,¿öµå,ÆÄ¿öÆ÷ÀÎÆ®)
  4. ±àÁ¤ÀûÀÎ ¸¶Àεå¿Í Ã¥ÀÓ°¨À» °¡Áö°í ¼ÒÅëÇÒ ¼ö ÀÖ´Â ºÐ
    • ¿ì´ë»çÇ×
      • PLC, SCADA ÇÁ·Î±×·¥ À¯Áö°ü¸® °æ·ÂÀÚ
      • ÆÄÀÌ½ã µî ºòµ¥ÀÌÅÍ ºÐ¼® ÇÁ·Î±×·¥ °æÇèÀÚ
      • Àü±â°ü·Ã ÀÚ°ÝÁõ ¼ÒÁöÀÚ
[°æ·Â] Life Science½Ç Marketing
°ø°í¸¶°¨ÀÏ
  • ä¿ë½Ã±îÁö ¸ðÁý (1Â÷ ¼­·ù¸¶°¨ 2024/10/13)
±Ù¹«Áö
  • Çѵ¶ º»»ç (¼­¿ï½Ã °­³²±¸ Å×Çì¶õ·Î 132)
°æ·Â±¸ºÐ
  • °æ·Â
Á÷¹«»ó¼¼
  • ºê·£µå»ç (QIAGEN/ EPPENDORF/ Cellsafe/ Advanced Instrument) PO °ü¸®, ¸¶ÄÉÆà Àü·« ¼ö¸³, È«º¸ È°µ¿, Á¦Ç°±³À°
  • ºê·£µå»ç ¹× ¿µ¾÷»ç¿ø, ³»ºÎ À¯°üºÎ¼­¿ÍÀÇ ¿øÈ°ÇÑ Communication
  • ¸¶ÄÉÆà ¿¹»ê Planning, ÁýÇà ¹× °ü¸®
  • ½ÃÀå µ¿Çâ ¹× °æÀï»ç Á¤º¸¸¦ ÅëÇÑ ¸¶ÄÏ ºÐ¼®
  • ½Å±Ô ºê·£µå °³¹ß
Áö¿øÀÚ°Ý
  • 4³âÁ¦ ´ëÇÐ ÀÌ»ó (»ý¸í°øÇÐ, »ý¹°ÇÐ, ÀÇ»ý¸í°úÇаú µî °ü·Ã Àü°ø ¹× °ü·Ã ¼®»ç ¿ì´ë)
  • µ¿Á¾ ¾÷°è 4³â ÀÌ»ó °æ·Â º¸À¯ÀÚ
  • ¿Ü±¹°è ÆÄÆ®³Ê»ç¿Í ±âº»ÀûÀÎ ¿µ¾î ÀÇ»ç¼ÒÅë °¡´ÉÀÚ (¿µ¾î Speaking Test ÁøÇà)
  • ¿îÀü¸éÇã ÀÚ°ÝÁõ º¸À¯ÀÚ (2Á¾ º¸Åë ÀÌ»ó)
[°æ·Â] ´ç´¢/¼øȯ±â Àü¹®ÀǾàÇ° Marketing
°ø°í¸¶°¨ÀÏ
  • 2024/10/20±îÁö
±Ù¹«Áö
  • Çѵ¶ º»»ç (¼­¿ï½Ã °­³²±¸ Å×Çì¶õ·Î 132)
°æ·Â±¸ºÐ
  • °æ·Â
Á÷¹«»ó¼¼ Àü¹®ÀǾàÇ° ¼øȯ±â ¿µ¿ªÀÇ Á¦Ç°À» ´ã´çÇÏ´Â Marketing
[Çѵ¶ Àü¹®ÀǾàÇ°]https://www.handok.co.kr/product/list/001/
  1. Marketing planning & implementation
    • Resource allocation: Products mix against targets, A&P allocation efficiency
    • Long-term franchise strategy and planning: portfolio growth, alliance/business partnership
    • Timely report the supervisor according to objectives mutually agreed upon from year-to-year.
    • Take a ownership of specific brand performance measures
    • Perform developmental project base such as secondary market research, data analysis and etc.
    • Conduct a variety of administrative functions such as medical legal mark-ups, material development, clinical study utilization & field force communication, all essential to the day to day operation of the brand
  2. Key customer management :
    • Regular visit to target physicians
    • Provide physicians with updated highly scientific information on product & disease
    • Shape physicians¡¯ view on the disease and establish need for product
  3. Scientific program support
    • Develop key speakers to become strong advocates for the product & therapeutic class
    • Lead scientific initiatives to build clinical evident and implement medical programs
    • Search & provide updated articles on the product and develop key message
    • Deliver MR product training
  4. People, Capabilities, and Management:
    • Talent acquisition
    • Responsible for compliance with all legal requirements of company policies and ensure strict compliance
Áö¿øÀÚ°Ý
  • More than 3 years marketing experience : Must
  • Commercial experience of Cardiovascular field in pharmaceutical firm : preferred
  • Intermediate English communication/Presentation skill
  • High level communication skills
  • Proven project management skill (in the planning and new business case) : Understanding of P&L analysis
  • Creative and innovative approaches to problem solving
  • Strategic orientation
  • Pro-activity and willingness to initiative
  • Ability to foster and manage productive biz relationship with external stakeholders
[Çѵ¶Á¦¼®Àç´Ü] Àç´Ü¿î¿µ ¹× Àü½Ã±âȹ ´ã´çÀÚ
°ø°í¸¶°¨ÀÏ
  • 2024/10/18
±Ù¹«Áö
  • Çѵ¶ º»»ç (¼­¿ï½Ã °­³²±¸ Å×Çì¶õ·Î)
°æ·Â±¸ºÐ
  • °æ·Â
Á÷¹«»ó¼¼ [¸ðÁýºÎ¹®¼³¸í]
ºñ¿µ¸® °øÀ͹ýÀÎÀÎ Çѵ¶Á¦¼®Àç´ÜÀº (ÁÖ)Çѵ¶°ú â¾÷ÁÖ Íº ±è½Å±Ç ȸÀå´ÔÀÇ ±âºÎ¸¦ ¹ÙÅÁÀ¸·Î ±â¾÷ÀÇ »çȸÀû Ã¥ÀÓÀ» ´ÙÇϱâ À§ÇØ 2006³â 3¿ù Ãâ¹üÇÏ¿´½À´Ï´Ù.
1964³â °³°üÇÑ Çѵ¶ÀǾà¹Ú¹°°üÀ» ÆíÀÔÇÏ¿© ÀǾàÇÐ ºÐ¾ßÀÇ ¿ª»ç¸¦ ¾Ë¸®±â À§ÇÑ Çѵ¶ÀǾà¹Ú¹°°ü ¿î¿µ, ÀǾàÇÐ ºÐ¾ß ÀåÇÐ ¹× ¿¬±¸ Áö¿ø, Áúº´ÅðÄ¡ ¹× ¼Ò¿Ü°èÃþ Áö¿ø»ç¾÷ µî ´Ù¾çÇÑ °øÀÍ»ç¾÷À» ÆîÄ¡°í ÀÖ½À´Ï´Ù.
  • ¹Ú¹°°ü ¿î¿µ °ü·Ã ¾÷¹« : Çѵ¶ÀǾà¹Ú¹°°ü ¼­¿ï ¿î¿µ, ±âȹ, È«º¸, ´º½º·¹ÅÍ ¹ßÇà µî
  • Àü½Ã ¹× °ø¿¬±âȹ : »ý¸í°¶·¯¸® Çö´ë ¹Ì¼ú ±âȹÀü½Ã, ¿¬ 1ȸ ÀÌ»ó ¸Þ¼¼³ª ¿¬°è Äܼ­Æ® ±âȹ ¹× ¿î¿µ
  • ÀǾà´ë ÀåÇлý ¹× ÀǾàÇÐ ¿¬±¸Áö¿ø »ç¾÷ ¿î¿µ
  • °øÀ͹ýÀÎ ¿î¿µ °ü·Ã ¾÷¹«(¿¹»ê Æí¼º ¹× ÁýÇà, ±âºÎ±Ý °ü¸®, Àç´Ü ÀÌ»çȸ ¿î¿µ µî)
  • Çѵ¶ ±â¾÷»çȸ°øÇåÆÀ°úÀÇ Çù¾÷(Çѵ¶ÀÓÁ÷¿ø ºÀ»ç´Ü HiºÀ»ç´Ü ¿î¿µ)
Áö¿øÀÚ°Ý
  • ÃÑ °æ·Â 7³â ÀÌ»ó
  • Àç´Ü¹ýÀÎ ±Ù¹«°æ·Â ÀÖ´Â ºÐ
  • ¹Ú¹°°ü/¹Ì¼ú°ü °ü·Ã ¾÷¹« À¯°æÇèÀÚ ¿ì´ë (Çп¹¿¬±¸»ç ÀÚ°ÝÁõ ¼ÒÁöÀÚ ¿ì´ë)
  • Àü½Ã ¹× °ø¿¬±âȹ ¿î¿µ À¯°æÇèÀÚ ¿ì´ë
  • ¿îÀü°¡´ÉÀÚ ¿ì´ë

ÀüÇü´Ü°è

Á¦Ãâ¼­·ù

  • ÃÖÁ¾ÇÕ°Ý ÈÄ Á¦Ãâ